Complex Relationships between Occupation, Environment, DNA Adducts, Genetic Polymorphisms and Bladder Cancer in a Case-Control Study Using a Structural Equation Modeling. by Porru, Stefano et al.
Complex Relationships between Occupation,
Environment, DNA Adducts, Genetic Polymorphisms and
Bladder Cancer in a Case-Control Study Using a
Structural Equation Modeling
Stefano Porru1, Sofia Pavanello2*, Angela Carta1, Cecilia Arici1, Claudio Simeone3, Alberto Izzotti4,
Giuseppe Mastrangelo2
1Department of Medical-Surgical Specialties, Radiological Sciences and Public Health, Section of Public Health and Human Sciences, University of Brescia, Brescia, Italy,
2Department of Cardiac, Thoracic, and Vascular Sciences, Unit of Occupational Medicine, University of Padova, Padova, Italy, 3Department of Medical-Surgical Specialties,
Radiological Sciences and Public Health, Section of Surgical Specialties, University of Brescia, Brescia, Italy, 4Department of Health Sciences, University of Genoa, Italy/
Mutagenesis Unit, IRCCS Hospital-University San Martino Company – IST National Institute for Cancer Research, Genoa, Italy
Abstract
DNA adducts are considered an integrate measure of carcinogen exposure and the initial step of carcinogenesis. Their levels
in more accessible peripheral blood lymphocytes (PBLs) mirror that in the bladder tissue. In this study we explore whether
the formation of PBL DNA adducts may be associated with bladder cancer (BC) risk, and how this relationship is modulated
by genetic polymorphisms, environmental and occupational risk factors for BC. These complex interrelationships, including
direct and indirect effects of each variable, were appraised using the structural equation modeling (SEM) analysis. Within the
framework of a hospital-based case/control study, study population included 199 BC cases and 213 non-cancer controls, all
Caucasian males. Data were collected on lifetime smoking, coffee drinking, dietary habits and lifetime occupation, with
particular reference to exposure to aromatic amines (AAs) and polycyclic aromatic hydrocarbons (PAHs). No indirect paths
were found, disproving hypothesis on association between PBL DNA adducts and BC risk. DNA adducts were instead
positively associated with occupational cumulative exposure to AAs (p = 0.028), whereas XRCC1 Arg 399 (p,0.006) was
related with a decreased adduct levels, but with no impact on BC risk. Previous findings on increased BC risk by packyears
(p,0.001), coffee (p,0.001), cumulative AAs exposure (p = 0.041) and MnSOD (p = 0.009) and a decreased risk by MPO (p,
0.008) were also confirmed by SEM analysis. Our results for the first time make evident an association between occupational
cumulative exposure to AAs with DNA adducts and BC risk, strengthening the central role of AAs in bladder carcinogenesis.
However the lack of an association between PBL DNA adducts and BC risk advises that these snapshot measurements are
not representative of relevant exposures. This would envisage new scenarios for biomarker discovery and new challenges
such as repeated measurements at different critical life stages.
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Introduction
Tobacco smoking and occupational exposures to aromatic
amines (AAs) and polycyclic aromatic hydrocarbons (PAHs) are
the major risk factors for bladder cancer (BC) [1,2]. Moreover
increasing evidence suggests a significant influence of genetic
predisposition on BC incidence [3,4].
The formation of reactive metabolites of AAs and PAHs and
their binding to DNA to give unrepaired/stable adducts, all
modulated by genetic polymorphisms of metabolic and DNA
repair enzymes, are considered critical events alongside the
theoretical pathway that links exposure to BC [5]. ‘‘Bulky’’
DNA adduct measurement has been therefore considered an
integrated marker of both exposure to aromatic compounds and
ability to activate carcinogens and repair DNA damage [6,7].
Significantly higher levels of aromatic DNA adducts have been
found in the bladder cancer biopsies from smokers [8,9].
Moreover persistent aromatic-DNA adducts causing mutations,
including mutational ‘‘hot spots’’ in the bladder P53 gene, has
provided a solid mechanistic view on how DNA adducts may drive
bladder tumourigenesis [10]. Furthermore, some DNA modifica-
tions induced by aromatic compounds in the bladder are found to
mirror those in the peripheral blood lymphocytes (PBLs) [11,12].
This has addressed the possibility of measuring such biomarker in
accessible tissues which can be easily and non-invasively obtained
from humans.
Many factors can however interfere in the theoretical pathway
that links carcinogenic exposure to BC, such as multiple exposures
(e.g., tobacco smoke, occupational exposure, fruit and vegetables
consumption), their characterization (e.g., level, route, reliability)
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as well as the modulating role (increasing, protecting or having no
effect) possibly played by polymorphic genes involved in metab-
olism and DNA repair [13]. To the best of our knowledge, only
few studies have explored the hypothesis that PBLs DNA adduct
levels can be associated to or predictive of BC risk. Results from
three retrospective hospital based case-control showed that the risk
indicator measuring the association between DNA adducts and
BC was higher than 1.0 [14,15], not different from unity [17], or
lower than 1.0 [16]. More precisely, DNA adducts were associated
to the risk of BC but independently from smoking habits [14,15],
while other authors [16] did not find any association between BC
risk and bulky DNA adducts in never smokers. In the nested case-
control prospective study, DNA adducts were not associated with
BC risk [17]; overall, these conflicting results are hard to be
explained from the biological viewpoint. Moreover, no study
apparently estimated the complex interactions between DNA
adducts, multiple genetic polymorphisms, occupational exposure
to AAs and PAHs, and BC risk.
We previously assessed the interaction between occupational
and environmental exposures with metabolic and DNA-repair
polymorphisms on the risk of BC in retrospective hospital based
case-control study [18–22].
The aim of this study was twofold: to investigate the extent to
which PBL DNA adducts and BC risk were separately affected by
genetic polymorphisms, environmental and occupational expo-
sures; and to explore whether the formation of DNA adducts
involved an additional increase in BC risk. These complex
interrelationships were appraised using the analysis of structural
equation modeling (SEM).
Subjects and Methods
Subjects
Study population, collection of data and statistical analysis are
described in previous publications [18–22].
Briefly, the design was a hospital-based case-control study. The
inclusion criteria were being male, aged between 20 and 80,
resident in the Brescia province (Northern Italy). The cases were
201 newly diagnosed, histologically confirmed BC patients,
admitted in the Urology Departments of the two main hospitals
of Brescia from July 1997 to December 2000. The controls were
214 patients affected by various urological non-neoplastic diseases,
frequency matched to cases by age (65 years), period and hospital
of admission. A written informed consent was obtained from each
recruited subject and the study was approved by the the Spedali
Civili di Brescia Ethical Committee.
All subjects were administered a questionnaire during hospital
admission to collect information on demographic variables and
lifetime history of smoking, coffee and other liquid consumption,
diet habits, occupations. Occupational exposures to PAHs and
AAs were estimated according to methodology described in
previous publication [22]. An index of cumulative exposure to AAs
and PAHs, separately, was calculated as product (i6f6l) of length
(l), intensity (i) and frequency (f) of exposure in each job, summing
up as many products as were necessary to take into account all jobs
done. Life-long consumption of cigarettes was calculated as
packyears. The lifelong time-weighted average of cups/day of
coffee was recoded as 0 (never drinkers), #3, 4, $5 cups/day.
PAHs containing food, fruit, large leaf vegetables and other
vegetables consumption was divided into four categories (less than
once/month; less than once/week; 1–3 times/week; more than
3 times/week).
Genotyping of GSTM1, GSTT1, GSTP1, NAT1, NAT2,
SULT1A1, XRCC1-3, XPD, CYP1A2, MPO, COMT, MnSOD
and NQO1 was assessed using Amplification Refractory Mutation
System assay and using the GeneAmp PCR System 9700 (Applied
Biosystems, Italy). PCR were followed by enzymatic digestion and
PCR-RFLP analysis, as previously described [18–22].
All variables proved to be associated with BC risk at univariable
logistic regression were forced in a multivariable unconditional
logistic regression model and then chosen by backwards stepwise
selection (with p,0.05 as criterion). BC risk significantly increased
with packyears, heavy coffee drinkers, MnSOD (Val/Val geno-
type), while decreased with large leaf vegetables consumption and
MPO (G-463A homozygous variant). Cumulative exposure to AAs
was not statistically significant but it was retained because being a
substantial confounder [19,22].
DNA extraction from PBLs
Blood samples were collected from all the subjects during
hospital admission and on the same day processed by centrifuga-
tion for obtaining peripheral blood lymphocytes (PBLs). The
protocol for automated DNA extraction was performed according
to Extragen kit (Extragen BC. by TALENT) following the
manufacturer’s instructions as previously described [20]. In
particular 2.5 ml of buffy coats prepared from up to 10 ml of
whole blood were processed for DNA extractions. A typical yield
ranged from 150 to 400 mg DNA/extraction from a normal
donor.
32P-Post-labeling analysis of DNA adducts
Aliquots of 5 mg DNA were assayed for the presence of bulky-
DNA adducts by 32P-postlabeling after enrichment with Nuclease
P1 as previously described [23,24]. Resolution of DNA adducts
was performed by multidirectional thin-layer chromatography
(TLC), using polyethyleneimine (PEI)-cellulose plates [25]. Briefly,
5 mg DNA were enzymatically digested to 39-mononucleotides
with 0,14 U/mg DNA of micrococcal nuclease and 1 mU/mg
DNA of spleen phosphodiesterase for 3–4 hours at 37uC. After the
enrichment procedure by Nuclease P1 digestion, DNA bases were
labelled with 50 mCi of [gamma-32P]ATP with a specific activity of
5000 Ci per mmol by using 2.5 units of T4 polynucleotide kinase.
20 ml of postlabeled sample were spotted on the origin of a
premarked PEI cellulose sheet and run for the multidirectional
TLC chromatography. Following chromatography, TLC sheets
were dried and electronic autoradiography performed using a 32P
imager (InstanImager, Packard, MD, USA). A benzo(a)-pyrene
diolepoxide-N2-dGp reference standard (National Cancer Insti-
tute Chemical Carcinogen Reference Standard Repository, Mid-
west Research Institute, Kansas City, Mo.) was used as a positive
control in each labeling experiment. DNA adducts levels were
measured as relative adduct level per 108 nucleotides.
Statistical analysis
In fitting SEM, packyears, coffee and vegetable consumption,
MnSOD, MPO, cumulative AA exposure (variables associated with
BC risk according to previous publications) plus XRCC1 (see
below) were used as exogenous variables (corresponding to
predictors in regression based techniques). Both BC risk and
adducts could be endogenous variables (corresponding to outcome
variables), each affected by one or more exogenous variables
(hypothesis 1). Alternatively, BC risk could be also influenced
indirectly through the formation of DNA adducts (hypothesis 2).
The two competing hypotheses were converted in two models of
structural equations to find which model fitted best the observed
data. SEM structural equations were fitted with ‘‘asymptotic
distribution free’’ method because it did not make assumption on
joint normality of all the variables and allowed using the variables
(particularly adducts, see below) as given. The effect of each
DNA Adducts on Bladder Cancer Risk by SEM Analysis
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exogenous variable was expressed as standardized (or beta)
coefficients that make comparisons easily by ignoring the
independent variable’s scale of units. SEM results were both
tabulated and presented graphically. We used two SEM’s
goodness-of-fit statistics: (1) the chi square test for ‘‘model versus
saturated’’ (the saturated model is the model that fits the
covariances perfectly); and (2) the stability index obtained from
the analysis of simultaneous equation systems.
The sample size required for SEM is dependent on model
complexity, the estimation method used, and the distributional
characteristics of observed variables [26]. The best option is to
consider the model complexity (i.e., the number of exogenous
variables) and the following rules of thumb: minimum ratio 5:1
[27,28]; recommended ratio 10:1 [26–28]; recommended ratio
15:1 for data with no normal distribution [29]. With eight
exogenous variables used in the SEM model, we should have 120
( = 1568) subjects but they were actually 412 (see below) fulfilling
the above requirements.
The analysis was carried out with the statistical package
STATA 12.
Results
In the present study, complete individual data were available for
199 (out of 201) cases and 213 (out of 214) controls, totaling 412
(instead of 415) subjects.
Table 1 shows the main characteristics of cases and controls.
Current and former smoking were more common (chi2 test (2df)
= 32.2377; p = 0.000) and coffee intake was higher (Wilcoxon
rank-sum test z =23.756; p= 0.0002) in cases than in controls. No
significant differences between cases and controls were found for
other demographic variables and putative risk factors of BC.
DNA adduct levels ranged from 0.3 to 70 adducts 6108
nucleotides; the variable did not follow a normal distribution and
any transformations failed to reduce its skewness (data not shown).
Table 2 shows that mean, standard deviation, median, inter-
quartile range and CV% of adduct levels were similar in cases and
controls. A multivariable linear regression model with backwards
stepwise selection gave XRCC1 as the only significant variable
carrying protective effect (data not shown).
Table 3 shows three groups of SEM results.
1. Structural equations. It can be seen the beta coefficients (with
‘‘minus’’ sign indicating an inverse relationship), standard
errors, z tests with p-values, and 95% confidence intervals for
each of two structural equation models. The first model shows
that cumulative occupational exposure to AAs (beta = 0.117;
p = 0.028) is associated with increased DNA adduct levels,
whereas XRCC1 Arg 399 (beta =20.129; p,0.006) with
decreased levels. We calculated the corresponding study-wise
p-value as (1-(1-alpha)n), where ‘‘alpha’’ was 0.006 and ‘‘n’’ was
6. The result was 0,035464301 (well below the threshold of
statistical significance), indicating that the error probability of
0.006 cannot be an effect of random fluctuations. The second
model shows that cigarette smoking (packyears; beta = 0.256;
p,0.001), coffee (beta = 0.166; p,0.001), cumulative occu-
pational AAs exposure (beta = 0.084; p= 0.041) and MnSOD
(beta = 0.119; p = 0.009) increased the BC risk whereas MPO
(beta =20.115; p,0.008) decreased it. No indirect paths were
demonstrated (disproving hypothesis 2).
2. Variance explained by the above fitting was about 4% for
DNA adducts and roughly 14% for the risk of BC.
3. Covariance between the two endogenous variables (BC risk
and adducts) was not significant (p = 0.441, last row of table 1).
This finding demonstrated that these variables were not
correlated to each other and that supported the hypothesis 2,
i.e., DNA adducts did not affect BC risk in our population.
The value of chi square test for the discrepancy of the specified
model versus saturated model was 0.00 with p-value equal to 1.00.
The stability index was 0.00, indicating that SEM satisfies stability
condition.
Using the graphical interface of SEM, the results shown in
table 3 were displayed as path diagram in figure 1. In this figure,
square boxes stand for variables, circles indicate variances, arrows
specify the direction of causal flow, an arrowed route is a path, and
the estimated beta coefficients appeared along the paths. The
effect of one variable on another is called direct. There was no
evidence of indirect effect (one variable affecting another variable
which in turn affects a third), indicating that bladder cancer risk in
our population was not further increased through formation of
DNA adducts.
Discussion
DNA adducts as outcome
Since DNA adducts in PBLs are considered an integrate
measure of carcinogen exposure, absorption, distribution, metab-
olism, and DNA repair, they have been referred to as biomarker of
‘biologically effective dose’ i.e. a measure of the amount of the
carcinogen at the critical target [13]. Moreover carcinogen DNA
adduct levels in more accessible circulating PBLs mirror those in
the bladder tissue [11,12], which are considered an initial step in
carcinogenesis.
However, in the present study, consistent with other literature
findings, bulky DNA adducts detected by the nuclease P1 method
of 32P-post-labeling were not associated with an increased BC risk,
probably because the adducts measured in PBLs at the time of BC
diagnosis represent snapshots that are not necessarily representa-
tive of exposures relevant for BC risk that occurred in the past.
Adduct levels were instead associated with XRCC1399Arg
carriers who presented a significant reduction in DNA adducts
level, but with no effect on the risk of BC. Our results agree with
previous studies reporting XRCC1399Arg associated with lower
levels of bulky DNA adducts [30,31], due to higher DNA repair
activity [32], and with two recent meta-analyses where XRCC1
Arg399Gln polymorphism was not related to BC risk [33,34].
In the present study, likewise the above reported studies
[14,15,17], no relationship between DNA adduct levels and
smoking was reported. Previous 32P-postlabeling studies have
reported inconsistent results on the association between the adduct
levels in PBLs and tobacco smoking [35–39]. Discrepancies may
depend on the marked interindividual variation in the metabolism
of smoking carcinogens, which results in different DNA adduct
levels for similar degrees of exposure [40]. Moreover, most of
studies on the effect of smoking on PBLs bulky-DNA adduct levels
did not reveal any significant differences [35,36,39], suggesting
that adducts in PBLs from smokers may result from sources other
than tobacco smoking.
We also found an association between cumulative occupational
exposure to AAs and PBL adduct levels that was instead not
reported by other authors most probably because information
about occupational exposures was too limited to allow evaluation,
even in the largest case-control study nested in EPIC cohort [17].
BC risk as outcome
We confirmed by SEM analysis the biological plausible
protective effect of MPO A/A [21], and the risk effect of MnSOD
DNA Adducts on Bladder Cancer Risk by SEM Analysis
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Val/Val on BC [21,41]. The genetic polymorphism of enzymes
involved in individual response to oxidative stress is likely involved
in modulating the individual response to environmental exposures
such as tobacco smoking, coffee drinks and AAs exposure [21]. In
this study we also confirmed our previous results on the association
between smoking habit and coffee drinking on BC risk, where the
latter might be attributed to residual confounding by inadequate
adjustment for cigarette smoking (which is over-represented
among those who drink the most coffee/caffeine) [22]. As shown
in table 3, the level of statistical significance of beta coefficients was
particularly high for the association between BC risk and, on the
other hand, packyears (beta = 0.256; p,0.001) and coffee (beta
= 0.166; p,0.001); as well as for the association between
decreased DNA adduct and XRCC1 Arg 399 (beta =20.129;
p,0.006). Despite this, the proportion to which SEM fitting
accounts for the dispersion of data (variance explained) was as low
as 16% for BC risk, and 4% for DNA adducts. Therefore most
variation of outcomes should be attributed to unknown predictors.
With regard to the relationship of occupational exposures to
AAs and PAHs, DNA adducts and BC risk the literature is scanty
and those few published studies have only found an exposure-
independent association between adducts and BC risk. Our study
precisely evaluated the occupational exposure history to AAs and
PAHs, and noted a significant correlation between occupational
exposure to AAs and BC, and adduct levels too. Therefore
occupational exposure to AAs is confirmed as central risk factor for
BC development. Finally the present work was carried out in the
context of a biologically plausible and hypothesis-driven study
design consistent with the available literature data.
Table 1. Distribution of demographic characteristics, life habits, and occupational exposures in cases and controls.
Cases (n =199) Controls (n =213)
Number (Percentage) Number (Percentage)
Age
#45 14 (7) 19 (9)
46–55 25 (13) 28 (13)
56–65 58 (29) 76 (36)
66–75 82 (41) 69 (32)
.75 20 (10) 21 (10)
Education
0–5 106 (54) 111 (53)
6–8 60 (30) 47 (22)
9–13 25 (13) 41 (20)
$14 7 (4) 11 (5)
Lifetime smoking
Never 17 (9) 54 (25)
Light (#26 packyears) 56 (28) 78 (37)
Heavy (.26 packyears) 126 (63) 81 (38)
Occupational cumulative exposure to PAHs
Never 128 (64) 143 (67)
Ever 71 (36) 70 (33)
Occupational cumulative exposure to AAs
Never 182 (91) 203 (95)
Ever 17 (9) 10 (5)
Coffee consumption (cups/day)
Mean (6 Standard Deviation) 2.33 (62.30) 1.58 (61.62)
5th–95th percentiles 0–8 0–6
doi:10.1371/journal.pone.0094566.t001
Table 2. Summary statistics (mean, standard deviation, median, interquartile range, number of subjects) for ‘‘ln_adducts’’ in cases,
controls, and total population.
Mean Std. Dev. CV% Median Inter quartile range N
Cases 0.82 1.20 146 0.57 2.00 185
Controls 0.77 1.09 142 0.46 1.73 180
Total 0.80 1.14 143 0.51 1.83 365
doi:10.1371/journal.pone.0094566.t002
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In addition, the correlation we found between AAs exposure
and BC risk is biologically plausible, because AAs are activated in
liver and transported by blood proteins to the bladder where,
under acidic conditions [42,43] or, enzymatically by O-acetylation
of N-hydroxy arylamine (predominantly by the N- acetyltransfer-
ase 1 (NAT1) isozyme), are further activated to the ultimate
carcinogen [44]. This result also suggests that occupational
exposure history collected by questionnaire through interview
could be a reliable measurement of exposures to AAs in such
studies.
Unlike AAs, cumulative exposure to PAHs was not associated
with BC risk. Experimental evidence suggests that PAHs are slowly
absorbed through most tissues. For instance, in the case of dermal
exposure, considered the main route in the industry [45],
absorption accounts for a small fraction of applied dose, and
PAHs are enzymatically activated and degraded at this site of
entry [46–48]. The concentration and persistence of PAHs in the
lung is largely related with inhalation of PAHs containing dust
[49,50]. The high propensity of PAHs to act as carcinogens at the
sites of entry is supported by several experimental studies [51].
DNA adducts and BC risk
The results of literature on the association between DNA
adducts and risk of BC are scanty and not consistent. A strong
direct association between and the risk of BC and PBLs DNA
adducts, measured at time of diagnosis and detected by means
nuclease P1 and 32P-postlabeling, was reported in two retrospec-
tive hospital based case-control [14,15]. The association was
however independent from smoking habits and was suggested to
be dependent from other exposures (that the studies did not
specify), and from NAT2 as genetic factor. While, in a retrospective
hospital based case-control among nonsmokers bulky DNA
adducts were not associated with bladder cancer risk [16]. Lastly
PBLs DNA adducts (nuclease P1 and 32P-postlabeling) were not
associated with the subsequent bladder cancer insurgence in a
prospective nested case-control study [17]. The findings of this
latter study are probably more reliable and meaningful than those
of earlier investigations [14,15], because DNA adducts were
measured years before the onset of disease, thus ruling out the
possibility that the higher adduct levels were due to a condition
associated with an already existing cancer.
We did not find any relation between DNA adducts and BC
risk. However, we cannot exclude such relationship. In fact, a
limitation of the present study is that adducts measured by
nuclease P1 method of 32P-postlabeling are non-specific because
the responsible electrophilic substance cannot be identified.
Moreover, DNA adducts measure at time of diagnosis may be
not representative of cumulative doses of carcinogens that may
cause cancer. Environmental and occupational exposures vary
both qualitatively and quantitatively over time due to changes in
lifestyle, place of residence, employment, etc., and the impact of a
given exposure on the risk of cancer cannot be constant
throughout the life of an individual [13]. This fact, combined
with the awareness that the rate and speed of repair of various
DNA adducts are different and their permanence mainly depends
from life span of PBLs, from a few days to a few weeks, poses
uncertainty on the significance of such short-term exposure
biomarker in relation to the risk of cancer. Given the long latency
of carcinogen-related malignancies – that is the time between the
beginning of exposure and the onset of disease – the retrospective
assessment of carcinogen exposures, especially via biomarkers,
represents a challenge for both epidemiology and clinical
medicine.
Perspectives (including SEM analysis)
New opportunities for biomonitoring of carcinogens may derive
from measuring exposures from all sources both external and
internal that occur throughout the lifespan. This approach named
exposome by Wild [52] is represented by the set of chemicals
derived from sources outside genetic control that include diet,
pathogens, microbiome, smoking, psychological stress, drugs and
pollution [53]. Indeed, these new technologies are opening new
scenarios for biomarker discovery but new challenges as well, that
include the need of repeated measurements of global sets of
biomarkers to be collected at different critical life stages. Only in
this way can the dynamics of exposures and early and late effects
be captured.
In medicine and natural sciences a given outcome is often
affected or influenced by more than one thing simultaneously.
Multivariate techniques try to statistically account for these
differences, adjusting an outcome measure Y to a 1 unit change
in X, holding all other variables constant. However, it may be that
other variables are not likely to remain constant: a change in X
can produce a change in Z (direct effect) which in turn produces a
change in Y (indirect effect). Both the direct and indirect effects of
X on Y must be considered if we want to know what effect a
change in X will have on Y. This can be done mathematically and
statistically only using SEM. The procedure decomposes a
correlation between two variables into its component parts: direct
effects, indirect effects, common causes (X affects both Y and Z;
this is spurious association) and correlated causes (X is a cause of Z
and X is correlated with Y). The user is required to state, often
using a path diagram, the way that he/she believes the variables
are inter-related. Via some complex internal rules, SEM decides
which model fits data better. This method is more suitable to
analyze complex interrelationships because it tests causal relation-
ships rather than mere correlations.
Figure 1. Path diagram of results shown in table 1. Variables
(square boxes); variances (circles); causal flow (arrows); and paths
(arrowed route). The estimated beta coefficients appeared along the
paths. LEGEND: Packyears = Life-long consumption of cigarettes;
Coffee = Life-long time-weighted average of cups/day of coffee; AA =
Occupational cumulative exposure to aromatic amines; XRCC1 = X-ray
repair cross-complementing protein 1; MPO = Myeloperoxidase (G-
463A homozygous variant); MnSOD = Manganese Superoxide Dis-
mutase (Val/Val genotype).
doi:10.1371/journal.pone.0094566.g001
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In our opinion, the statistical analysis with SEM is one strength
of the present research. Other strengths of the study are the
thorough and reliable collection of several personal, occupational
and environmental variables, the multiple genetic polymorphisms
and endpoints, the significant number of subjects, as compared to
other similar studies with adduct analysis [14–17], the quality of
DNA adduct analysis, the sample size required for calculation of
SEM; here, the actual number of 412 cases was much higher than
the maximum required sample size of 120 subjects estimated
according to different assumptions (see above: statistical analysis).
Conclusions
Using the SEM analysis, a statistical technique that combines
observed data and qualitative causal assumptions and tests
whether and how variables are interrelated through a system of
equations, we found that PBL DNA adducts was not associated
with BC risk. This suggests that this measure at time of diagnosis
may be not representative of dose of carcinogens that may cause
cancer. However the new finding stemming from this study
sustains that occupational cumulative exposure to AAs were
instead associated with both DNA adducts and with BC risk. This
agrees with the propensity of AAs to act as carcinogens away of the
sites of entry after being transported by blood proteins to the
bladder and confirm exposure to AAs, determined by blood DNA
adduct, as central risk factor for BC development. Moreover
XRCC1399Arg polymorphism has a role in repairing PBL DNA
adducts but no impact on individual susceptibility to BC. Previous
findings on the influence of smoking, coffee intake, MPO A/A and
MnSOD Val/Val polymorphisms on BC risk were also confirmed
by SEM analysis. A direct effect of these predictor variables was
observed on each outcome variable. Our study envisages new
scenarios, entailing the need of repeated DNA adduct measure-
ments at different critical life stages and proper analytical
techniques, for example during occupational exposure to AAs, as
well as the appraisal of the complex relationship between gene and
environment, by means of SEM analysis.
Author Contributions
Conceived and designed the experiments: SP SP GM. Performed the
experiments: SP AC CA SP AI CS GM. Analyzed the data: SP AC CA SP
AI CS GM. Contributed reagents/materials/analysis tools: SP AC CA SP
AI CS GM. Wrote the paper: SP AC CA SP AI CS GM.
References
1. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C (2006) Mechanisms
of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 3: 327–340.
2. Bosetti C, Boffetta P, La Vecchia C (2007) Occupational exposures to polycyclic
aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative
review to 2005. Ann Oncol 18: 431–446.
3. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, et al. (2013)
Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63: 234–
241.
4. Chu H, Wang M, Zhang Z (2013) Bladder cancer epidemiology and genetic
susceptibility. J Biomed Res 27: 170–178.
5. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, et al. (2002)
Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-
associated cancers. Oncogene 21: 7435–7451.
6. Pavanello S, Pulliero A, Clonfero E (2008) Influence of GSTM1 null and low
repair XPC PAT+ on anti-B[a]PDE-DNA adduct in mononuclear white blood
cells of subjects low exposed to PAHs through smoking and diet. Mutat Res 638:
195–204.
7. Loeb LA, Harris CC (2008) Advances in chemical carcinogenesis: a historical
review and prospective. Cancer Res 68: 6863–6872.
8. Talaska G, Al-Juburi AZSS, Kadlubar FF (1991) Smoking related carcinogen–
DNA adducts in biopsy samples of human urinary bladder: identification of N-
(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci
USA 88: 5350–5354.
9. Talaska G, Schamer M, Casetta G, Tizzani A, Vineis P (1994) Carcinogen-DNA
adducts in bladder biopsies and urothelial cells: a risk assessment exercise.
Cancer Lett 84: 93–97.
10. Yoon JI, Kim SI, Tommasi S, Besaratinia A (2012) Organ specificity of the
bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in
mice. Cancer Prev Res (Phila) 5: 299–308.
11. Zhou Q, Talaska G, Jaeger M, Bhatnagar VK, Hayes RB, et al. (1997)
Benzidine-DNA adduct levels in human peripheral white blood cells significantly
correlate with levels in exfoliated urothelial cells. Mutat Res 393: 199–205.
12. Airoldi L, Orsi F, Magagnotti C, Coda R, Randone D, et al. (2002)
Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies.
Carcinogenesis 23: 861–866.
13. Wild CP (2009) Environmental exposure measurement in cancer epidemiology.
Mutagenesis 24: 117–125.
14. Peluso M, Airoldi L, Armelle M, Martone T, Coda R, et al. (1998) White blood
cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder
cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 7: 341–346.
15. Peluso M, Airoldi L, Magagnotti C, Fiorini L, Munnia A, et al. (2000) White
blood cell DNA adducts and fruit and vegetable consumption in bladder cancer.
Carcinogenesis 21: 183–187.
16. Castan˜o-Vinyals G, Talaska G, Rothman N, Alguacil J, Garcia-Closas M, et al.
(2007) Bulky DNA adduct formation and risk of bladder cancer. Cancer
Epidemiol Biomarkers Prev 16: 2155–2159.
17. Peluso M, Munnia A, Hoek G, Krzyzanowski M, Veglia F, et al. (2005) DNA
adducts and lung cancer risk: a prospective study. Cancer Res 65: 8042–8048.
18. Covolo L, Placidi D, Gelatti U, Carta A, Scotto Di Carlo A, et al. (2008) Bladder
cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic
polymorphisms and coffee consumption: a case-control study. Eur J Epidemiol
23: 355–362.
19. Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, et al. (2004)
GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with
environmental exposures and bladder cancer risk in a high-risk population.
Int J Cancer 110: 598–604.
20. Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, et al. (2003)
Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction
with environmental exposures, and bladder cancer risk in a case–control study in
northern Italy. Cancer Epidemiol Biomarkers Prev 12: 1234–1240.
21. Hung RJ, Boffetta P, Brennan P, Malaveille C, Gelatti U, et al. (2004) Genetic
polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with
environmental exposures and bladder cancer risk. Carcinogenesis 25: 973–978.
22. Pavanello S, Mastrangelo G, Placidi D, Campagna M, Pulliero A, et al. (2010)
CYP1A2 polymorphisms, occupational and environmental exposures and risk of
bladder cancer. Eur J Epidemiol 25: 491–500.
23. Pavanello S, Levis AG (1994) Human peripheral blood lymphocytes as a cell
model to evaluate the genotoxic effect of coal tar treatment. Environ Health
Perspect 102 Suppl 9: 95–99.
24. Izzotti A (1998) Detection of modified DNA nucleotides by postlabelling
procedures. Toxicology Methods 8:175–205.
25. Gupta RC, Reddy MV, Randerath K (1982) 32P-postlabeling analysis of non-
radioactive aromatic carcinogen—DNA adducts. Carcinogenesis 3: 1081–1092.
26. Kline R (2005) Principles and Practice of Structural Equation Modeling (2nd
ed.). New York: The Guilford Press.
27. Bentler P, Chou C (1987) Practical issues in structural modeling. Sociological
Methods and Research 16: 78–117.
28. Worthington R, Whittaker T (2006) Scale Development Research. A Content
Analysis and Recommendations for Best Practices. The Counseling Psychologist
34: 806–838.
29. Hair J, Black W, Babin B, Anderson R, Tatham R (2006) Multivariate Data
Analysis (6th ed.). New Jersey: Pearson Educational, Inc.
30. Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, et al. (2001) XRCC1,
XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a
sample of healthy subjects. Carcinogenesis 22: 1437–445.
31. Ji G, Gu A, Zhou Y, Shi X, Xia Y, et al. (2010) Interactions between exposure to
environmental polycyclic aromatic hydrocarbons and DNA repair gene
polymorphisms on bulky DNA adducts in human sperm. PLoS One 5(10) pii:
e13145.
32. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA (1999) XRCC1
polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant
frequency. Cancer Res 59: 2557–2561.
33. Fang Z, Chen F, Wang X, Yi S, Chen W, et al. (2013) XRCC1 Arg194Trp and
Arg280His polymorphisms increase bladder cancer risk in asian population:
evidence from a meta-analysis. PLoS One 8(5): e64001.
34. Zhuo W, Zhang L, Cai L, Zhu B, Chen Z (2013) XRCC1 Arg399Gln
polymorphism and bladder cancer risk: updated meta-analyses based on 5767
cases and 6919 controls. Exp Biol Med (Maywood) 238: 66–76.
35. Phillips DH, Schoket B, Hewer A, Bailey E, Kostic S, et al. (1990) Influence of
cigarette smoking on the levels of DNA adducts in human bronchial epithelium
and white blood cells. Int J Cancer 46: 569–575.
36. Phillips DH, Hewer A, Grover PL (1986) Aromatic DNA adducts in human
bone marrow and peripheral blood leukocytes. Carcinogenesis 7: 2071–2075.
DNA Adducts on Bladder Cancer Risk by SEM Analysis
PLOS ONE | www.plosone.org 7 April 2014 | Volume 9 | Issue 4 | e94566
37. Jahnke GA, Thompson CL, Walker MP, Gallagher JE, Lucier GW, et al. (1990)
Multiple DNA adducts in lymphocytes of smokers and nonsmokers determined
by 32-P-postlabelling analysis. Carcinogenesis 11: 205–211.
38. Savela K, Hemmink K (1991) DNA adducts in lymphocytes and granulocytes of
smokers and nonsmokers detected by the 32-P-postlabelling assay. Carcinogen-
esis 12: 503–508.
39. Van Maanen JMS, Maas LM, Hageman G, Kleinjans JCS, Van Agen B (1994)
DNA adduct and mutation analysis in white blood cell s of smokers and non-
smokers. Environ Mol Mutagen 24: 46–50.
40. Perera FP (1996) Molecular epidemiology: insights into cancer susceptibility, risk
assessment, and prevention. J NatI Cancer Inst 88: 496–507.
41. Sutton A, Khoury H, Prip-Buus C, Cepanec C, Pessayre D, et al. (2003) The
Ala16Val genetic dimorphism modulates the import of human manganese
superoxide dismutase into rat liver mitochondria. Pharmacogenetics 13: 145–
157.
42. Kadlubar FF (1991) Carcinogenic aromatic amine metabolism and DNA adduct
detection in human. In: Emster L, editor. Xenobiotics and cancer. London:
Taylor & Francis, Ltd. pp. 329–338.
43. Bartsch H, Malaveille C, Friesen M, Kadlubar FF, Vineis P (1993) Black (air-
cured) and blond (flue-cured) tobacco cancer risk. IV. Molecular dosimetrys-
tudies implicates aromatic amines as bladder carcinogens. Eur J Cancer 29:
1199–1207.
44. Frederickson SM, Messing EM, Renikoff CA, Swaminathan S (1994)
Relationship between in vivo acetylator phenotypes and cytosolic N-acetyl-
transferase and O-acetyltransferase activities in human uroepithelial cells.
Cancer Epidemiol Biomark Prev 3: 25–32.
45. Jongeneelen FJ (1992) Biological exposure limit for occupational exposure to
coal tar pitch volatiles at cokeovens. Int Arch Occup Environ Health 63: 511–
516.
46. Kao J, Patterson FK, Hall J (1985) Skin penetration and metabolism of topically
applied chemicals in six mammalian species, including man: an in vitro study
with benzo[a]pyrene and testosterone. Toxicol Appl Pharmacol 81: 502–516.
47. Ng KM, Chu I, Bronaugh RL, Franklin CA, Somers DA (1992) Percutaneous
absorption and metabolism of pyrene, benzo[a]pyrene, and di(2-ethylhexyl)
phthalate: comparison of in vitro and in vivo results in the hairless guinea pig.
Toxicol Appl Pharmacol 115: 216–223
48. VanRooij JG, De Roos JH, Bodelier-Bade MM, Jongeneelen FJ (1993)
Absorption of polycyclic aromatic hydrocarbons through human skin:
differences between anatomical sites and individuals. J Toxicol Environ Health
38:355–368.
49. Albert RE, Miller ML, Cody T, Andringa A, Shukla R, et al. (1991)
Benzo[a]pyrene-induced skin damage and tumor promotion in the mouse.
Carcinogenesis 12: 1273–1280.
50. Wolterbeek AP, Schoevers EJ, Rutten AA, Feron VJ (1995) A critical appraisal
of intratracheal instillation of benzo[a]pyrene to Syrian golden hamsters as a
model in respiratory tract carcinogenesis. Cancer Lett 89: 107–116.
51. IARC (2010) IARC monographs on the evaluation of carcinogenic risks to
humans. Some non-heterocyclic polycyclic aromatic hydrocarbons and some
related exposures. Volume 92. International Agency for Research on Cancer,
Lyon, France39.
52. Wild CP (2012) The exposome: from concept to utility. Int J Epidemiol 41: 24–
32.
53. Rappaport SM (2012) Biomarkers intersect with the exposome. Biomarkers
17(6):483–9.
DNA Adducts on Bladder Cancer Risk by SEM Analysis
PLOS ONE | www.plosone.org 8 April 2014 | Volume 9 | Issue 4 | e94566
